Genetically driven CD39 expression affects Sezary cell viability, IL-2 production and detects two patient subsets with distinct prognosis

MLA

Picozza, Mario, et al. “Genetically Driven CD39 Expression Affects Sezary Cell Viability, IL-2 Production and Detects Two Patient Subsets with Distinct Prognosis.” Journal of Investigative Dermatology, no. Preprints, Jan. 2022. EBSCOhost, https://doi.org/10.1016/j.jid.2022.04.017.

APA

Picozza, M., Cristofoletti, C., Bresin, A., Fioretti, M., Sambucci, M., Scala, E., Monopoli, A., Cantonetti, M., Pilla, M. A., Accetturi, M. P., Borsellino, G., D, A. S., Caprini, E., Russo, G., & Narducci, M. G. (2022). Genetically driven CD39 expression affects Sezary cell viability, IL-2 production and detects two patient subsets with distinct prognosis. Journal of Investigative Dermatology, Preprints. https://doi.org/10.1016/j.jid.2022.04.017

Chicago

Picozza, Mario, Cristina Cristofoletti, Antonella Bresin, Martina Fioretti, Manolo Sambucci, Enrico Scala, Alessandro Monopoli, et al. 2022. “Genetically Driven CD39 Expression Affects Sezary Cell Viability, IL-2 Production and Detects Two Patient Subsets with Distinct Prognosis.” Journal of Investigative Dermatology, no. Preprints (January). doi:10.1016/j.jid.2022.04.017.